BioCryst Pharmaceuticals Inc logo

BioCryst Pharmaceuticals Inc

NEW
FRA:BO1 (USA)   Ordinary Shares
€ 7.81 -0.30 (-3.72%) Jul 17
At Loss
Market Cap:
€ 2.07B ($ 2.37B)
Enterprise V:
€ 2.58B ($ 2.95B)
Volume:
0
Avg Vol (2M):
641.00
Trade In:

BioCryst Pharmaceuticals Inc (FRA:BO1) Dividend

BioCryst Pharmaceuticals Inc (FRA:BO1) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -4.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:BO1 Dividend

Does BioCryst Pharmaceuticals Inc (FRA:BO1) pay a dividend?

BioCryst Pharmaceuticals Inc (FRA:BO1) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BioCryst Pharmaceuticals Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BioCryst Pharmaceuticals Inc has returned capital to shareholders via buybacks at a rate of -4.3% over the past 3 years.

What are dividend-paying alternatives to BioCryst Pharmaceuticals Inc?

For dividend-paying alternatives in BioCryst Pharmaceuticals Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.